- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT07560423
Patient Satisfaction Following Multidisciplinary Cancer Care Assessment in Day Hospital: A Prospective Observational Study. (EVAQSAP-HDJ-BC)
Evaluation and Analysis of Patient Satisfaction Following Multidisciplinary Complex Assessment in Day Hospital: Determinants and Implications for Continuous Quality Improvement
This study aims to evaluate patient satisfaction following a multidisciplinary "complex assessment" conducted in a Day Hospital setting at the Centre Hospitalier de Martigues. This assessment is part of routine care for patients diagnosed with cancer and scheduled to receive injectable anticancer treatment.
During this assessment, patients meet several healthcare professionals, including a pharmacist, dietitian, psychologist, social worker, and supportive care providers. The objective is to identify patient-specific needs and improve coordination of care at an early stage of the treatment pathway.
This is a prospective observational study based on an anonymous satisfaction questionnaire distributed to eligible adult patients after completion of the Day Hospital assessment. The primary objective is to assess overall patient satisfaction. Secondary objectives include evaluating satisfaction by specialty, identifying factors associated with satisfaction, and assessing the Net Promoter Score (NPS).
The results of this study are expected to help identify strengths and areas for improvement in multidisciplinary care, enhance patient-centered care, and support continuous quality improvement in oncology practice.
Przegląd badań
Status
Interwencja / Leczenie
Szczegółowy opis
Cancer care requires a multidisciplinary and patient-centered approach to address the complex medical, psychological, and social needs of patients. In this context, a "complex assessment" program has been implemented in the Day Hospital (HDJ) of the Centre Hospitalier de Martigues for patients with various types of cancer (breast, gynecological, urological, digestive, hematological, and pulmonary) prior to initiation of injectable anticancer therapies.
This program involves coordinated consultations with multiple healthcare professionals, including a pharmacist, dietitian, psychologist, social worker, and supportive care providers. The aim is to identify vulnerabilities, optimize supportive care, and improve the overall patient care pathway.
This study is designed as a prospective observational study evaluating patient satisfaction with this multidisciplinary intervention. All eligible adult patients who undergo the Day Hospital complex assessment are invited to complete an anonymous satisfaction questionnaire. The questionnaire includes items related to the quality of care, interactions with healthcare professionals, organization of care, and overall satisfaction, as well as a Net Promoter Score (NPS).
The primary endpoint is the proportion of patients reporting high overall satisfaction. Secondary endpoints include satisfaction levels by healthcare professional category, identification of determinants associated with satisfaction, and evaluation of the NPS according to demographic and clinical characteristics.
Statistical analyses will include descriptive statistics, univariate and multivariate analyses to identify factors associated with patient satisfaction. Results from this study will provide valuable insights into patient experience and contribute to the continuous improvement of multidisciplinary oncology care in a non-university hospital setting.
Typ studiów
Zapisy (Szacowany)
Kontakty i lokalizacje
Kontakt w sprawie studiów
- Nazwa: Gwladys M'BOUNGOU Clinical study manager, Msc
- Numer telefonu: +33 0442432469
- E-mail: gwladys.mboungou@ch-martigues.fr
Kopia zapasowa kontaktu do badania
- Nazwa: MARTIN Gwenola healthcare manager of the day hospital, Diploma in Health Care Managem
- Numer telefonu: +33-04 42 43 27 56
- E-mail: Gwenola.MARTIN@ch-martigues.fr
Lokalizacje studiów
-
-
Bouches du Rhone
-
Martigues, Bouches du Rhone, Francja, 13500
- Rekrutacyjny
- Centre Hospitalier de Martigues
-
Kontakt:
- Gwladys M'BOUNGOU Clinical study Manager, Master of Pharmacy (Pharmacolo
- Numer telefonu: +33 0442432469
- E-mail: gwladys.mboungou@ch-martigues.fr
-
Kontakt:
- MARTIN Gwenola healthcare manager of the day hospital, Diploma in Health Care Managem
- Numer telefonu: +33 +33-04 42 43 27 56
- E-mail: Gwenola.MARTIN@ch-martigues.fr
-
Główny śledczy:
- GERARDIN Eric, doctor
-
Pod-śledczy:
- CHEVALIER Thomas, doctor
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
- Dorosły
- Starszy dorosły
Akceptuje zdrowych ochotników
Metoda próbkowania
Badana populacja
Opis
Inclusion Criteria:
- Adult patients (≥ 18 years old)
- Patients undergoing a multidisciplinary "complex assessment" in a Day Hospital setting
- Patients diagnosed with cancer and scheduled to receive injectable anticancer treatment
- Ability to understand and complete the satisfaction questionnaire
- Patients who have been informed and have not opposed participation
Exclusion Criteria:
- Patients under 18 years of age
- Patients unable to complete the questionnaire (e.g., severe cognitive impairment or major language barrier)
- Patients who refuse participation
- Patients with incomplete Day Hospital complex assessment
- Patients under legal protection (guardianship or curatorship)
Patients under legal protection (guardianship or curatorship)
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
Kohorty i interwencje
Grupa / Kohorta |
Interwencja / Leczenie |
|---|---|
|
Patients undergoing multidisciplinary complex assessment in Day Hospital
Adult patients with cancer undergoing a multidisciplinary "complex assessment" in a Day Hospital setting prior to initiation of injectable anticancer treatment, including consultations with healthcare professionals and completion of a satisfaction questionnaire.
|
Routine multidisciplinary assessment conducted in a Day Hospital setting involving consultations with healthcare professionals (pharmacist, dietitian, psychologist, social worker, and supportive care providers) as part of standard oncology care.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Overall Patient Satisfaction
Ramy czasowe: At completion of the Day Hospital assessment (within 1 month after assessment)
|
Proportion of patients reporting high overall satisfaction following the multidisciplinary complex assessment, measured using an anonymous satisfaction questionnaire.
|
At completion of the Day Hospital assessment (within 1 month after assessment)
|
Współpracownicy i badacze
Sponsor
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Szacowany)
Ukończenie studiów (Szacowany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 2024-A02062-45-EVAQSAP-HDJ-BC
- 2024-A02062-45 (Inny identyfikator: ANSM)
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Opis planu IPD
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .